EDGAR·FLOW

Larimar Therapeutics, Inc. — Form 10-Q

Filed November 16, 2026 · analyzed by the Periodic Agent
10-Q — Neutral significance 48/100
What the filing says
Larimar hired John B. Harlow, Jr. as President and Chief Operating Officer effective September 29, 2026 with an annual base salary of $560,000, a one-time signing bonus of $35,000, target annual bonus of 40% of base salary, 800,000 stock options (25% vesting at year 1, then 75% over 36 months), and 50,000 restricted stock units (vesting over 4 years). A First Amendment added whistleblower protections. No specific counterparty other than the executive or financial terms beyond compensation are disclosed.
Why this rating

Routine executive hire. Total comp ~$595K cash + equity is material (~0.6% of $94.7M market cap), but CEO hiring is ordinary business. Equity grant dilutes existing holders but is standard incentive practice.

View original filing on SEC.gov ↗ LRMR · stock on Yahoo Finance ↗

See more from November 16, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.